|
Days abstinent from heroin, median (IQR)
|
15 (8,24)
|
18 (2,22)
|
17 (11,23)
|
18 (8,24)
|
18 (8,20)
|
18 (8,27)
|
20 (12,26)
|
23 (14,26)
|
25 (14,27)
|
|
LDQ total, median (IQR)
|
14 (8,17)
|
9 (5,16)
|
10 (6.6,16)
|
11 (5,15)
|
6 (5,12)
|
7 (4,10)
|
7 (2,13)
|
6 (3,12)
|
5 (2,13)
|
|
CORE
|
|
Wellbeing, median (IQR)
|
2 (2,3)
|
2 (0.8,2.5)
|
2 (1.3,2.9)
|
2 (1,2)
|
1.6 (0.8,2.1)
|
1.5 (0.8,2)
|
2 (1,2)
|
1.3 (0.8,2)
|
1.5 (0.8,2.3)
|
|
Symptoms, median (IQR)
|
2 (2,3)
|
2.1 (0.9,2.9)
|
2.4 (1.1,2.6)
|
2 (1,2)
|
1.3 (1,2.3)
|
1.5 (0.8,2)
|
2 (1,3)
|
1.3 (1,2.3)
|
1.6 (0.8,2.3)
|
|
Functioning, median (IQR)
|
2 (2,3)
|
1.8 (1.2,2.6)
|
2.2 (1,2.7)
|
2 (1,2)
|
1.5 (1.1,2)
|
1.6 (0.8,2)
|
2 (1,2)
|
1.5 (1.1,2.1)
|
1.2 (0.8,1.9)
|
|
SSQ total, median (IQR)
|
23 (19,26)
|
24 (22,28)
|
24 (19.5,27)
|
22 (18,25)
|
23 (19,24)
|
22 (20,26)
|
23 (20,27)
|
24 (20,28)
|
24 (22,27)
|
|
CEST
|
|
Counselling rapport, median (IQR)
|
40 (38,43)
|
41 (38,43)
|
39 (35,46)
|
39 (36,42)
|
39 (38,42)
|
40 (39,42)
|
40 (39,43)
|
40 (39,44)
|
41 (40,48)
|
|
Peer support, median (IQR)
|
32 (28,40)
|
30 (26,38)
|
30 (25,37)
|
30 (28,34)
|
30 (28,32)
|
30 (26,34)
|
32 (28,38)
|
32 (26,36)
|
36 (28,38)
|
|
Treatment participation, median (IQR)
|
38 (33,39)
|
38 (36,39)
|
38 (31,42)
|
37 (35,38)
|
37 (35,38)
|
38 (35,40)
|
38 (34,41)
|
39 (37,42)
|
41 (40,47)
|
|
Treatment satisfaction, median (IQR)
|
39 (35,41)
|
40 (36,43)
|
40 (35,40)
|
39 (37,41)
|
39 (37,41)
|
40 (36,42)
|
40 (39,43)
|
40 (39,44)
|
41 (40,47)
|
|
ISEL
|
|
Appraisal, median (IQR)
|
16 (15,19)
|
17 (15,18)
|
18 (14,21)
|
16 (14,18)
|
18 (16,20)
|
18 (16,20)
|
16 (15,18)
|
18 (17,20)
|
18 (16,20)
|
|
Belonging, median (IQR)
|
17 (14,19)
|
16 (14,18)
|
17 (14,19.5)
|
15 (13,17)
|
17 (15,19.5)
|
16 (14.5,19.5)
|
17 (15,18)
|
17 (16,20)
|
18 (15,21.5)
|
|
Self-esteem, median (IQR)
|
14 (12,17)
|
14 (13,15)
|
13.5 (12,16.5)
|
14 (12,16)
|
15 (14,17)
|
15 (14,18)
|
16 (13,18)
|
15 (14,18)
|
15 (14,20)
|
|
Tangible, median (IQR)
|
17 (13,19)
|
16 (14,19)
|
16 (14,19.5)
|
15 (14,19)
|
16 (15,19)
|
18 (14.5,19.5)
|
16 (14,18)
|
16 (14,17)
|
17.5 (15.5,21)
|
|
IPDA
|
|
Index 1-network size (IQR)
|
−0.42 (−0.66,0.24)
|
0.07 (−0.83,0.83)
|
−0.29 (−0.74,1.01)
|
− 0.18 (− 0.66,0.64)
|
−0.14 (− 0.83,0.65)
|
0.12 (− 0.74,0.49)
|
0.24 (− 0.18,1.0)
|
0.07 (− 0.83,1.18)
|
0.12 (− 0.29,0.84)
|
|
Index 2–daily network size (IQR)
|
− 0.50 (−1.06,0.06)
|
− 0.10 (− 0.58,0.37)
|
−0.49 (− 0.76,0.06)
|
−0.06 (− 0.50,1.18)
|
−0.10 (− 0.58,0.37)
|
−0.49 (− 0.49,0.61)
|
−0.22 (− 0.50,0.06)
|
−0.50 (− 0.50,0.62)
|
0.06 (− 0.49,0.61)
|
|
Index 3-importance (IQR)
|
−0.14 (− 0.65,0.62)
|
0.17 (− 0.33,0.75)
|
−0.12 (− 0.58,0.67)
|
−0.02 (− 1.08,1.25)
|
−0.01 (− 0.89,0.94)
|
−0.12 (− 0.62,0.38)
|
−0.02 (− 0.86,1.25)
|
−0.01 (− 0.43,0.75)
|
0.38 (− 0.12,1.14)
|
|
Component 1: substance involvement (IQR)
|
−0.40 (− 0.93,0.05)
|
−0.35 (− 0.83,0.62)
|
−0.28 (− 0.79,1.14)
|
−0.06 (− 0.44,0.67)
|
−0.24 (− 0.51,0.34)
|
−0.37 (− 0.84,0.16)
|
−0.24 (− 0.75,0.85)
|
−0.49 (− 0.66,0.47)
|
−0.07 (− 0.58,0.57)
|
|
Component 2: general/treatment support (IQR)
|
0.14 (− 0.56,0.66)
|
−0.04 (− 0.48,0.57)
|
0.24 (− 0.58,0.66)
|
−0.49 (− 1.03, 0.30)
|
−0.10 (− 0.50,0.74)
|
−0.14 (− 0.83,0.43)
|
0.48 (− 0.35,1.02)
|
0.09 (− 0.17,0.77)
|
0.34 (− 0.30,0.82)
|
|
Component 3-support for substance use (IQR)
|
0.16 (− 0.86,0.89)
|
0.25 (− 0.75,0.82)
|
0.48 (− 0.72,1.37)
|
0.34 (− 0.86,0.89)
|
0.08 (−0.75,0.68)
|
− 0.51 (− 0.94,0.90)
|
0.02 (− 0.86,0.72)
|
0.07 (− 1.02,0.57)
|
−0.51 (− 0.94,0.68)
|
|
RCQ-TV, median (IQR)
|
4.5 (4,7)
|
5 (4,6)
|
4 (4,7)
|
4 (3,5)
|
4 (3,5)
|
4 (4,6)
|
4.5 (4,6)
|
4 (4,6)
|
5 (4,7)
|
